advancedQTc prolongationcitalopramgeriatricEKGtorsades de pointesFDAlab interpretation
A 70-year-old female with a history of well-controlled MDD on citalopram 20 mg presents with a corrected QTc interval of 485 ms on a routine EKG. She is asymptomatic. What is the MOST appropriate assessment and action?